Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025 2025-06-01 15:00
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma 2025-06-01 09:39
Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session 2025-06-01 08:00
CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients 2025-05-31 10:27
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG) 2025-05-30 22:00
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001 2025-05-30 21:30
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal 2025-05-30 15:02
Concord Healthcare Announces Official Release of the Proton Therapy Large Model 2025-05-30 04:30
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA 2025-05-30 00:01
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT 2025-05-29 21:04
Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence 2025-05-29 20:30
Grit Biotechnology Presents Clinical Breakthroughs at 2025 ASCO Annual Meeting 2025-05-29 20:30
AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation 2025-05-29 20:00
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval 2025-05-29 20:00
China's HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC 2025-05-29 17:27
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA 2025-05-29 11:47
Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities 2025-05-28 21:00
Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain 2025-05-28 20:00
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography 2025-05-28 20:00
CARsgen's Satri-cel Granted Priority Review by the NMPA 2025-05-28 12:10